David S. Maxwell

机构：The University of Texas MD Anderson Cancer Center, University of Oklahoma Health Sciences Center · ORCID：0000-0001-5926-8501

发表论文 133 篇 · 总被引 22238 次 · h-index 37

代表论文

canSAR 2024—an update to the public drug discovery knowledgebase (2024 · Nucleic Acids Research · 被引 19)
A Context-Aware Target Engagement and Pharmacodynamic Biomarker Resource to Accelerate Drug Discovery and Development (2026 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 1)
Abstract 31: Charles: A self-critical agentic AI drug discovery analyst for cancer. (2026 · Cancer Research · 被引 1)
PocketBagger: Generalizable pocket druggability prediction via positive–unlabeled learning (2026 · bioRxiv (Cold Spring Harbor Laboratory))
Abstract 2720: A comprehensive LLM-enabled pharmacodynamic biomarker resource to accelerate cancer drug development. (2026 · Cancer Research)
26-CCC-13315-ACC FROM HEARTACHE TO HEADACHE: NEW ONSET MIGRAINES AFTER TRANSSEPTAL ABLATION IN ADOLESCENTS (2026 · Journal of the American College of Cardiology)